360disruption

360Disruption is an official Channel Partner of Ajman Free Zone Authority – one of the UAE’s most dynamic and accessible free zones. This strategic partnership opens a powerful new chapter for our platform, and more importantly, for the U.S. healthtech and biotech innovators we work with. ✅ Why This Matters Ajman Free Zone (AFZ) is fast becoming a preferred launchpad for next-gen companies — and for good reason: Streamlined setup : Company formation in as little as 1 day. Cost-effective licensing : Ideal for early-stage innovators and lean market entry Strategic location : Minutes from Sharjah and Dubai, with direct access to UAE’s health corridors Forward-thinking leadership : Open to new business models, pilot projects, and disruptive ventures Flexibility : 100% foreign ownership, full repatriation of profits, no currency restrictions This makes AFZ the perfect home for U.S.-based firms wanting to localize operations, build GCC credibility, and pilot their solutions in a welcoming ...

Most Early-Stage Biotech Playbooks make one point crystal clear: science alone isn’t enough. Early-stage biotech ventures must be execution-first, ecosystem-aware, and expansion-ready — especially when scaling across borders. At 360Disruption, we didn’t need a playbook to realize this — we built our entire platform on it. Whether enabling vaccine localization with Verndari, launching a sleep diagnostics JV with Pioneer Diagnostics, or onboarding breakthrough longevity science from Calroy and Kimera Labs, 360Disruption is the go-to-market command center for biotech scaleups entering the UAE and GCC. What the Playbook Gets Right — and What We Deliver According to most Playbooks, early-stage biotech ventures must tackle six key areas: Translational Science to Market Fit Most biotech founders focus on the molecule or modality — but fail to define the real-world use case, patient need, or payer value. → At 360Disruption, we reframe the science into a health system solution — aligning wi...